Literature DB >> 15973529

Resolution of medullary nephrocalcinosis in children with metabolic bone disorders.

Ari Auron1, Uri S Alon.   

Abstract

Ultrasonographic resolution of nephrocalcinosis (NC) has been reported in children with furosemide-induced NC, but not in other entities. We report the cases of four children with metabolic bone disease, two with hypophosphatasia and two with X-linked hypophosphatemic rickets, in whom we observed resolution of renal calcifications. At the time of ultrasonographic resolution of NC, 3 of the patients were on anticalciuric diuretics, and all 4 had normal urinalysis, serum creatinine and electrolyte profiles, as well as estimated creatinine clearance. In 3 of the children, evidence of mild tubular dysfunction was found. It thus seems that in some children with bone and mineral disorders who develop NC, ultrasonographic resolution of the renal calcifications can be seen; however, mild tubular dysfunction may remain and require follow-up. Further studies are suggested to explore the possible role of anticalciuric diuretics in promoting the resolution of NC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15973529     DOI: 10.1007/s00467-005-1899-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  22 in total

1.  Effect of thiazide on established furosemide-induced nephrocalcinosis in the young rat.

Authors:  S Knoll; U S Alon
Journal:  Pediatr Nephrol       Date:  2000-01       Impact factor: 3.714

Review 2.  Hypophosphatasia.

Authors:  D P Brenton; S Krywawych
Journal:  Clin Rheum Dis       Date:  1986-12

3.  Effects of therapy in X-linked hypophosphatemic rickets.

Authors:  C F Verge; A Lam; J M Simpson; C T Cowell; N J Howard; M Silink
Journal:  N Engl J Med       Date:  1991-12-26       Impact factor: 91.245

4.  Kidney function in very low birth weight infants with furosemide-related renal calcifications at ages 1 to 2 years.

Authors:  G J Downing; J C Egelhoff; D K Daily; M K Thomas; U Alon
Journal:  J Pediatr       Date:  1992-04       Impact factor: 4.406

5.  Infantile hypophosphatasia: treatment options to control hypercalcemia, hypercalciuria, and chronic bone demineralization.

Authors:  J P Barcia; C F Strife; C B Langman
Journal:  J Pediatr       Date:  1997-05       Impact factor: 4.406

6.  Histological long-term outcome of furosemide-induced nephrocalcinosis in the young rat.

Authors:  U S Alon; R A Kaplan; L L Gratny; M A Nichols
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

7.  Incidence, ultrasonic patterns and resolution of nephrocalcinosis in very low birthweight infants.

Authors:  T Saarela; A Vaarala; P Lanning; M Koivisto
Journal:  Acta Paediatr       Date:  1999-06       Impact factor: 2.299

8.  Renal acidification in children with idiopathic hypercalciuria.

Authors:  M Bonilla-Felix; O Villegas-Medina; V M Vehaskari
Journal:  J Pediatr       Date:  1994-04       Impact factor: 4.406

9.  Nephrocalcinosis in X-linked hypophosphatemia: effect of treatment versus disease.

Authors:  A Taylor; N H Sherman; M E Norman
Journal:  Pediatr Nephrol       Date:  1995-04       Impact factor: 3.714

Review 10.  Interactions of drugs with the developing kidney.

Authors:  D L Blowey; S Ben-David; G Koren
Journal:  Pediatr Clin North Am       Date:  1995-12       Impact factor: 3.278

View more
  9 in total

Review 1.  The tubular epithelium in the initiation and course of intratubular nephrocalcinosis.

Authors:  Benjamin A Vervaet; Anja Verhulst; Marc E De Broe; Patrick C D'Haese
Journal:  Urol Res       Date:  2010-08-02

Review 2.  Hypercalcemia: a consultant's approach.

Authors:  Ari Auron; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2017-09-06       Impact factor: 3.714

Review 3.  FGF23 and Associated Disorders of Phosphate Wasting.

Authors:  Anisha Gohil; Erik A Imel
Journal:  Pediatr Endocrinol Rev       Date:  2019-09

4.  Ultrasound is superior to computed tomography for assessment of medullary nephrocalcinosis in hypoparathyroidism.

Authors:  Alison M Boyce; Thomas H Shawker; Suvimol C Hill; Peter L Choyke; Michael C Hill; Robert James; Nancy A Yovetich; Michael T Collins; Rachel I Gafni
Journal:  J Clin Endocrinol Metab       Date:  2013-01-24       Impact factor: 5.958

Review 5.  Hypophosphatasia: Biological and Clinical Aspects, Avenues for Therapy.

Authors:  Jean Pierre Salles
Journal:  Clin Biochem Rev       Date:  2020-02

6.  Effects of growth hormone treatment on adult height in severely short children with X-linked hypophosphatemic rickets.

Authors:  Nadine Meyerhoff; Dieter Haffner; Hagen Staude; Elke Wühl; Michaela Marx; Rolf Beetz; Uwe Querfeld; Martin Holder; Heiko Billing; Wolfgang Rabl; Carmen Schröder; Olaf Hiort; Jürgen H Brämswig; Annette Richter-Unruh; Dirk Schnabel; Miroslav Živičnjak
Journal:  Pediatr Nephrol       Date:  2017-10-20       Impact factor: 3.714

Review 7.  Hypophosphatemic rickets due to perturbations in renal tubular function.

Authors:  Maria Goretti M G Penido; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2013-05-01       Impact factor: 3.714

8.  Acute vitamin d toxicity in an infant.

Authors:  Rajesh Khadgawat; Ravinder Goswami; Nandita Gupta; Asu Seith; Ajay Prakash Mehta
Journal:  Clin Pediatr Endocrinol       Date:  2007-11-17

9.  Rare case of nephrocalcinosis in a 14-year-old girl: Answers.

Authors:  Omar Bjanid; Piotr Adamczyk; Małgorzata Stojewska; Dagmara Roszkowska-Bjanid; Magdalena Paszyna-Grześkowiak; Agnieszka Jędzura; Joanna Oświęcimska; Katarzyna Ziora; Aurelia Morawiec-Knysak; Maria Szczepańska
Journal:  Pediatr Nephrol       Date:  2016-07-06       Impact factor: 3.714

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.